Clinical trials
Phase 1/2 Waldenstrom Macroglobulinemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 4 |
| 2004 | 2 |
| 2005 | 6 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 6 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 36 |
| Terminated | 12 |
| Recruiting | 5 |
| Unknown status | 4 |
| Active, not recruiting | 3 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 10 |
| Mayo Clinic | 6 |
| Fred Hutchinson Cancer Center | 4 |
| BeiGene | 2 |
| Idera Pharmaceuticals, Inc. | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Northwestern University | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| Acerta Pharma BV | 1 |
| Acrotech Biopharma Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Waldenstrom Macroglobulinemia | 62 |
| Lymphoma, Follicular | 44 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 42 |
| Lymphoma, B-Cell, Marginal Zone | 42 |
| Lymphoma, Mantle-Cell | 41 |
| Lymphoma, Large B-Cell, Diffuse | 34 |
| Lymphoma, Non-Hodgkin | 32 |
| Burkitt Lymphoma | 25 |
| Hodgkin Disease | 25 |
| Lymphoma | 22 |
Trials
Showing 26 to 50 of 62. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.